Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001654954-17-003323
Filing Date
2017-04-14
Accepted
2017-04-14 16:14:31
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT AMENDMENT NO. 9 end_s1a9.htm S-1/A 1746422
2 CONSENTS OF EXPERTS AND COUNSEL end_ex231.htm EX-23.1 3475
3 IMAGE end_drs000.jpg GRAPHIC 6647
4 IMAGE end_drs003.jpg GRAPHIC 16014
5 IMAGE end_drs006.jpg GRAPHIC 6647
6 IMAGE img.jpg GRAPHIC 19347
7 IMAGE page53graphic.jpg GRAPHIC 16355
8 IMAGE page54graphic.jpg GRAPHIC 16051
  Complete submission text file 0001654954-17-003323.txt   1863439
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-214724 | Film No.: 17762968
SIC: 3845 Electromedical & Electrotherapeutic Apparatus